Safety vs price in the generic drug market: metformin
CONCLUSIONS: Recalls of metformin ER medications were effective in lowering NDMA levels below the FDA threshold; however, some samples of generic metformin still contained carcinogens even after FDA-announced recalls. The absence of any correlation with price indicates that potentially safer products are available on the market for the same price as poorer-quality products.PMID:38603530 | DOI:10.37765/ajmc.2024.89450 (Source: The American Journal of Managed Care)
Source: The American Journal of Managed Care - April 11, 2024 Category: Health Management Authors: Ben Teasdale Amber Hudspeth Kaury Kucera David Light Jill Nailor Shannon Williams Arnold Milstein Kevin A Schulman Source Type: research
Safety vs price in the generic drug market: metformin
CONCLUSIONS: Recalls of metformin ER medications were effective in lowering NDMA levels below the FDA threshold; however, some samples of generic metformin still contained carcinogens even after FDA-announced recalls. The absence of any correlation with price indicates that potentially safer products are available on the market for the same price as poorer-quality products.PMID:38603530 | DOI:10.37765/ajmc.2024.89450 (Source: The American Journal of Managed Care)
Source: The American Journal of Managed Care - April 11, 2024 Category: Health Management Authors: Ben Teasdale Amber Hudspeth Kaury Kucera David Light Jill Nailor Shannon Williams Arnold Milstein Kevin A Schulman Source Type: research
Safety vs price in the generic drug market: metformin
CONCLUSIONS: Recalls of metformin ER medications were effective in lowering NDMA levels below the FDA threshold; however, some samples of generic metformin still contained carcinogens even after FDA-announced recalls. The absence of any correlation with price indicates that potentially safer products are available on the market for the same price as poorer-quality products.PMID:38603530 | DOI:10.37765/ajmc.2024.89450 (Source: The American Journal of Managed Care)
Source: The American Journal of Managed Care - April 11, 2024 Category: Health Management Authors: Ben Teasdale Amber Hudspeth Kaury Kucera David Light Jill Nailor Shannon Williams Arnold Milstein Kevin A Schulman Source Type: research
Safety vs price in the generic drug market: metformin
CONCLUSIONS: Recalls of metformin ER medications were effective in lowering NDMA levels below the FDA threshold; however, some samples of generic metformin still contained carcinogens even after FDA-announced recalls. The absence of any correlation with price indicates that potentially safer products are available on the market for the same price as poorer-quality products.PMID:38603530 | DOI:10.37765/ajmc.2024.89450 (Source: The American Journal of Managed Care)
Source: The American Journal of Managed Care - April 11, 2024 Category: Health Management Authors: Ben Teasdale Amber Hudspeth Kaury Kucera David Light Jill Nailor Shannon Williams Arnold Milstein Kevin A Schulman Source Type: research
Safety vs price in the generic drug market: metformin
CONCLUSIONS: Recalls of metformin ER medications were effective in lowering NDMA levels below the FDA threshold; however, some samples of generic metformin still contained carcinogens even after FDA-announced recalls. The absence of any correlation with price indicates that potentially safer products are available on the market for the same price as poorer-quality products.PMID:38603530 | DOI:10.37765/ajmc.2024.89450 (Source: The American Journal of Managed Care)
Source: The American Journal of Managed Care - April 11, 2024 Category: Health Management Authors: Ben Teasdale Amber Hudspeth Kaury Kucera David Light Jill Nailor Shannon Williams Arnold Milstein Kevin A Schulman Source Type: research
Safety vs price in the generic drug market: metformin
CONCLUSIONS: Recalls of metformin ER medications were effective in lowering NDMA levels below the FDA threshold; however, some samples of generic metformin still contained carcinogens even after FDA-announced recalls. The absence of any correlation with price indicates that potentially safer products are available on the market for the same price as poorer-quality products.PMID:38603530 | DOI:10.37765/ajmc.2024.89450 (Source: The American Journal of Managed Care)
Source: The American Journal of Managed Care - April 11, 2024 Category: Health Management Authors: Ben Teasdale Amber Hudspeth Kaury Kucera David Light Jill Nailor Shannon Williams Arnold Milstein Kevin A Schulman Source Type: research
Safety vs price in the generic drug market: metformin
CONCLUSIONS: Recalls of metformin ER medications were effective in lowering NDMA levels below the FDA threshold; however, some samples of generic metformin still contained carcinogens even after FDA-announced recalls. The absence of any correlation with price indicates that potentially safer products are available on the market for the same price as poorer-quality products.PMID:38603530 | DOI:10.37765/ajmc.2024.89450 (Source: The American Journal of Managed Care)
Source: The American Journal of Managed Care - April 11, 2024 Category: Health Management Authors: Ben Teasdale Amber Hudspeth Kaury Kucera David Light Jill Nailor Shannon Williams Arnold Milstein Kevin A Schulman Source Type: research
Safety vs price in the generic drug market: metformin
CONCLUSIONS: Recalls of metformin ER medications were effective in lowering NDMA levels below the FDA threshold; however, some samples of generic metformin still contained carcinogens even after FDA-announced recalls. The absence of any correlation with price indicates that potentially safer products are available on the market for the same price as poorer-quality products.PMID:38603530 | DOI:10.37765/ajmc.2024.89450 (Source: The American Journal of Managed Care)
Source: The American Journal of Managed Care - April 11, 2024 Category: Health Management Authors: Ben Teasdale Amber Hudspeth Kaury Kucera David Light Jill Nailor Shannon Williams Arnold Milstein Kevin A Schulman Source Type: research
Safety vs price in the generic drug market: metformin
CONCLUSIONS: Recalls of metformin ER medications were effective in lowering NDMA levels below the FDA threshold; however, some samples of generic metformin still contained carcinogens even after FDA-announced recalls. The absence of any correlation with price indicates that potentially safer products are available on the market for the same price as poorer-quality products.PMID:38603530 | DOI:10.37765/ajmc.2024.89450 (Source: The American Journal of Managed Care)
Source: The American Journal of Managed Care - April 11, 2024 Category: Health Management Authors: Ben Teasdale Amber Hudspeth Kaury Kucera David Light Jill Nailor Shannon Williams Arnold Milstein Kevin A Schulman Source Type: research
Safety vs price in the generic drug market: metformin
CONCLUSIONS: Recalls of metformin ER medications were effective in lowering NDMA levels below the FDA threshold; however, some samples of generic metformin still contained carcinogens even after FDA-announced recalls. The absence of any correlation with price indicates that potentially safer products are available on the market for the same price as poorer-quality products.PMID:38603530 | DOI:10.37765/ajmc.2024.89450 (Source: The American Journal of Managed Care)
Source: The American Journal of Managed Care - April 11, 2024 Category: Health Management Authors: Ben Teasdale Amber Hudspeth Kaury Kucera David Light Jill Nailor Shannon Williams Arnold Milstein Kevin A Schulman Source Type: research
Safety vs price in the generic drug market: metformin
CONCLUSIONS: Recalls of metformin ER medications were effective in lowering NDMA levels below the FDA threshold; however, some samples of generic metformin still contained carcinogens even after FDA-announced recalls. The absence of any correlation with price indicates that potentially safer products are available on the market for the same price as poorer-quality products.PMID:38603530 | DOI:10.37765/ajmc.2024.89450 (Source: The American Journal of Managed Care)
Source: The American Journal of Managed Care - April 11, 2024 Category: Health Management Authors: Ben Teasdale Amber Hudspeth Kaury Kucera David Light Jill Nailor Shannon Williams Arnold Milstein Kevin A Schulman Source Type: research
Safety vs price in the generic drug market: metformin
CONCLUSIONS: Recalls of metformin ER medications were effective in lowering NDMA levels below the FDA threshold; however, some samples of generic metformin still contained carcinogens even after FDA-announced recalls. The absence of any correlation with price indicates that potentially safer products are available on the market for the same price as poorer-quality products.PMID:38603530 | DOI:10.37765/ajmc.2024.89450 (Source: The American Journal of Managed Care)
Source: The American Journal of Managed Care - April 11, 2024 Category: Health Management Authors: Ben Teasdale Amber Hudspeth Kaury Kucera David Light Jill Nailor Shannon Williams Arnold Milstein Kevin A Schulman Source Type: research
Efficacy of combinational treatment versus nicotinamide monotherapy in the prevention of ultraviolet radiation-induced skin cancer
CONCLUSION: NAM-PG was as effective in delaying UVR-induced tumour onset as NAM-mono. The reduction in 6-4PP lesions may indicate that the mechanism of NAM-PG is better suited for photoprotection than NAM-mono. NAM-mono was superior to NAM-Met, indicating a dose-dependency of NAM's photoprotection. These results highlight a potential for combining photoprotective compounds to enhance photoprotection.PMID:38599196 | DOI:10.1159/000538445 (Source: Cancer Control)
Source: Cancer Control - April 10, 2024 Category: Cancer & Oncology Authors: Celina Pihl Flemming Andersen Peter Bjerring Merete Haedersdal Catharina Margrethe Lerche Source Type: research
Associations Among Diabetes Medication Use, Serum Magnesium, and Insulin Resistance in a Cohort of Older Puerto Rican Adults
CONCLUSIONS: Diabetes medication, especially metformin, was associated with elevated odds of hypomagnesemia, which may weaken the association between metformin and lowering of HOMA-IR. The causal inference needs to be confirmed in further studies.PMID:38599521 | DOI:10.1016/j.ajcnut.2024.04.005 (Source: The American Journal of Clinical Nutrition)
Source: The American Journal of Clinical Nutrition - April 10, 2024 Category: Nutrition Authors: Fan Chen Kelsey M Mangano Mahdi Garelnabi Kellee Cardaleen Katherine L Tucker Source Type: research
Associations Among Diabetes Medication Use, Serum Magnesium, and Insulin Resistance in a Cohort of Older Puerto Rican Adults
CONCLUSIONS: Diabetes medication, especially metformin, was associated with elevated odds of hypomagnesemia, which may weaken the association between metformin and lowering of HOMA-IR. The causal inference needs to be confirmed in further studies.PMID:38599521 | DOI:10.1016/j.ajcnut.2024.04.005 (Source: Am J Clin Nutr)
Source: Am J Clin Nutr - April 10, 2024 Category: Nutrition Authors: Fan Chen Kelsey M Mangano Mahdi Garelnabi Kellee Cardaleen Katherine L Tucker Source Type: research
